GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (STU:29Y) » Definitions » FCF Yield %

Spexis AG (STU:29Y) FCF Yield % : -198.03 (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Spexis AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Spexis AG's Trailing 12-Month Free Cash Flow is €-8.02 Mil, and Market Cap is €4.04 Mil. Therefore, Spexis AG's FCF Yield % for today is -198.03%.

The historical rank and industry rank for Spexis AG's FCF Yield % or its related term are showing as below:

STU:29Y' s FCF Yield % Range Over the Past 10 Years
Min: -15036.64   Med: -95.81   Max: -7.65
Current: -198.03


During the past 10 years, the highest FCF Yield % of Spexis AG was -7.65%. The lowest was -15036.64%. And the median was -95.81%.

STU:29Y's FCF Yield % is ranked worse than
92.14% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs STU:29Y: -198.03

Spexis AG's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.


Spexis AG FCF Yield % Historical Data

The historical data trend for Spexis AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG FCF Yield % Chart

Spexis AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.84 -45.16 -0.65 -0.22 -2.45

Spexis AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.64 -0.29 -2.81 -1.96 -1.17

Competitive Comparison of Spexis AG's FCF Yield %

For the Biotechnology subindustry, Spexis AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spexis AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Spexis AG's FCF Yield % falls into.



Spexis AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Spexis AG's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-12.131 / 494.29632
=-2.45%

Spexis AG's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.179 * 2 / 543.096064
=-1.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spexis AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Spexis AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Spexis AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Spexis AG (STU:29Y) Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 125, Allschwil, CHE, CH-4123
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (STU:29Y) Headlines

No Headlines